---  
layout: startup_page  
title: "Obsidian Therapeutics"  
id: "obsidiantx.com"  
permalink: "/obsidiantherapeuticsobsidiantx.com04032024/"  
website: "https://www.obsidiantx.com/"  
funding_round: "Series C"  
funding_amount: "$160.5M"  
investors: "Wellington Management, Foresite Capital, Janus Henderson Investors, Novo Holdings A/S, Paradigm BioCapital, RTW Investments, T. Rowe Price, Woodline Partners LP, Atlas Venture, Blue Owl Healthcare Opportunities, Bristol Myers Squibb, Deep Track Capital, Logos Capital, RA Capital Management, TCGX, Samsara BioCapital, Surveyor Capital"  
about: "Obsidian Therapeutics is a clinical-stage biotechnology company developing engineered cell and gene therapies. Their lead program, OBX-115, is a novel engineered tumor-infiltrating lymphocyte (TIL) cell therapy designed to improve the treatment of advanced or metastatic melanoma and other solid tumors. The company utilizes its proprietary cytoDRiVEÂ® technology for precise regulation of protein function."  
markets: "Biotechnology, Cell Therapy, Gene Therapy, Oncology, Health Care, Pharmaceutical"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2015"  
linkedin: "https://www.linkedin.com/company/obsidian-therapeutics/"  
twitter: "https://twitter.com/obsidian_tx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/obsidian-therapeutics"  
pitchbook: ""  

date_display: "03-Apr-2024"  
date: "2024-04-03"

# SEO Optimization  
meta_title: "Obsidian Therapeutics - Series C Funding ($160.5M)"  
meta_description: "Obsidian Therapeutics, Obsidian Therapeutics is a clinical-stage biotechnology company developing engineered cell and gene therapies. Their lead program, OBX-115, is a novel..."  
meta_keywords: "Obsidian Therapeutics, Biotechnology, Cell Therapy, Gene Therapy, Oncology, Health Care, Pharmaceutical, Series C funding"  
canonical_url: "https://startup.projectstartups.com/obsidiantherapeuticsobsidiantx.com04032024/"  
---